Income Statement Trinity Biotech plc

Stocks

TRIB

US8964385046

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 21:00:00 10/07/2026 BST			5-day change	1st Jan Change
0.3868 ^USD	-1.15%		+2.74%	-51.10%

07-08	European Equities Traded in the US as American Depositary Receipts Decline Sharply in Wednesday Trading	MT
07-07	European Equities Traded in the US as American Depositary Receipts Decline in Tuesday Trading	MT

390053736c.KTwti-QOr8h1WBpo2qS2WlEZr-wd78NmB8qzngVNUqA.UXAes7Zf95A0NFQCo-DSORRP47h2jZcwcaLb7FAOFOptan7jgWHHqgMLQw

Published financial data: TRINITY BIOTECH PLC

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	92.96M	74.78M	56.83M	61.56M	43.78M
Total Revenues	92.96M	74.78M	56.83M	61.56M	43.78M
Cost of Goods Sold, Total	54.89M	52.73M	37.38M	40.11M	26.9M
Gross Profit	38.08M	22.05M	19.45M	21.44M	16.89M
Selling General & Admin Expenses, Total	24.68M	29.17M	31.15M	28.82M	24.67M
R&D Expenses	4.5M	4.14M	4.38M	4.54M	3.63M
Other Operating Expenses	-4K	-336K	-3K	1.79M	-1.87M
Other Operating Expenses, Total	29.18M	32.97M	35.53M	35.14M	26.43M
Operating Income	8.9M	-10.92M	-16.08M	-13.7M	-9.55M
Interest Expense, Total	-7.1M	-11.54M	-10.15M	-11.91M	-12.81M
Interest And Investment Income	3K	-	-	-	-
Net Interest Expenses	-7.09M	-11.54M	-10.15M	-11.91M	-12.81M
Other Non Operating Income (Expenses)	1.22M	228K	1.17M	-1.17M	-202K
EBT, Excl. Unusual Items	3.03M	-22.23M	-25.06M	-26.78M	-22.55M
Restructuring Charges	-	-	-	-4.18M	-4.25M
Impairment of Goodwill	-54K	-	-	-1.6M	-2.14M
Gain (Loss) On Sale Of Investments	-	-	-1.5M	800K	-
Asset Writedown	-6.31M	-5.36M	-9.6M	-612K	-33K
Other Unusual Items	4.08M	-13.6M	-767K	1.64M	-8.19M
EBT, Incl. Unusual Items	751K	-41.19M	-36.93M	-30.73M	-37.18M
Income Tax Expense	-178K	-192K	-59K	486K	199K
Earnings From Continuing Operations	929K	-41M	-36.87M	-31.22M	-37.38M
Earnings Of Discontinued Operations	-54K	-7K	12.85M	-573K	-
Net Income to Company	875K	-41.01M	-24.02M	-31.79M	-37.38M
Net Income - (IS)	875K	-41.01M	-24.02M	-31.79M	-37.38M
Net Income to Common Incl Extra Items	875K	-41.01M	-24.02M	-31.79M	-37.38M
Net Income to Common Excl. Extra Items	929K	-41M	-36.87M	-31.22M	-37.38M
Per Share Items
Net EPS - Basic	0.21	-6.08	-3.14	-1.77	-2.01
Basic EPS - Continuing Operations	0.22	-6.08	-4.82	-1.74	-2.01
Basic Weighted Average Shares Outstanding	4.18M	6.75M	7.65M	17.96M	18.58M
Net EPS - Diluted	0.19	-6.08	-3.14	-1.83	-2.01
Diluted EPS - Continuing Operations	0.2	-6.08	-4.82	-1.8	-2.01
Diluted Weighted Average Shares Outstanding	4.18M	6.75M	7.65M	17.96M	18.58M
Normalized Basic EPS	0.45	-2.06	-2.05	-0.93	-0.76
Normalized Diluted EPS	0.45	-2.06	-2.05	-0.93	-0.76
American Depositary Receipts Ratio (ADR)	20	20	20	20	20
Supplemental Items
EBITDA	10.55M	-9.52M	-14.3M	-13.03M	-8.24M
EBITA	9.34M	-10.48M	-15.13M	-13.7M	-9.54M
EBIT	8.9M	-10.92M	-16.08M	-13.7M	-9.55M
EBITDAR	-	-	-	-	-
Effective Tax Rate - (Ratio)	-23.7	0.47	0.16	-1.58	-0.54
Current Domestic Taxes	-511K	-	-	-	-
Current Foreign Taxes	296K	-	-	-	-
Total Current Taxes	-215K	-275K	264K	285K	465K
Deferred Domestic Taxes	118K	-	-	-	-
Deferred Foreign Taxes	-81K	-	-	-	-
Total Deferred Taxes	37K	83K	-323K	201K	-266K
Normalized Net Income	1.89M	-13.9M	-15.66M	-16.74M	-14.1M
Interest Capitalized	-	-	-	-	2.9M
Interest on Long-Term Debt	5.46M	24.74M	10.15M	10.74M	4.53M
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	7.03M	9.24M	8.06M	7.33M	7.14M
Net Rental Expense, Total	-	-	-	-	-
Imputed Operating Lease Interest Expense	-	-	-	-	-
Imputed Operating Lease Depreciation	-	-	-	-	-
Stock-Based Comp., COGS (Total)	5K	-	-	-	-
Stock-Based Comp., SG&A Exp. (Total)	1.1M	1.76M	2.07M	1.32M	324K
Stock-Based Comp., Other (Total)	-	-	-	-	-
Total Stock-Based Compensation	1.1M	1.76M	2.07M	1.32M	324K

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	25.91M	6.58M	3.69M	5.17M	5.14M
Short Term Investments	-	-	-	-	-
Total Cash And Short Term Investments	25.91M	6.58M	3.69M	5.17M	5.14M
Accounts Receivable, Total	14.17M	13.44M	11.34M	13.88M	9.69M
Other Receivables	1.54M	2.21M	1.67M	728K	594K
Total Receivables	15.71M	15.66M	13.01M	14.6M	10.28M
Inventory	29.12M	22.5M	19.93M	19.37M	18.83M
Prepaid Expenses	1.94M	1.93M	2.04M	1.98M	1.65M
Other Current Assets, Total	-	-	373K	-	-
Total Current Assets	72.69M	46.67M	39.04M	41.12M	35.9M
Gross Property Plant And Equipment	63.46M	65.61M	66.07M	70.62M	72.82M
Accumulated Depreciation	-57.54M	-59.92M	-64.18M	-66M	-67.52M
Net Property Plant And Equipment	5.92M	5.68M	1.89M	4.62M	5.3M
Long-term Investments	-	-	-	2.46M	2.77M
Goodwill	12.54M	12.54M	0	13.84M	13.97M
Other Intangibles, Total	5.76M	5.72M	1.17M	16.55M	19.45M
Accounts Receivable Long-Term	151K	84K	36K	-	-
Deferred Tax Assets Long-Term	4.1M	4.22M	1.98M	3.55M	3.92M
Deferred Charges Long-Term	17.68M	17.01M	15.1M	20.95M	23.57M
Other Long-Term Assets, Total	56K	183K	221K	194K	277K
Total Assets	119M	92.1M	59.44M	103M	105M
Liabilities
Accounts Payable, Total	6.76M	6.2M	3.88M	6.83M	11.48M
Accrued Expenses, Total	8.12M	9.06M	8.07M	14.37M	17.62M
Short-term Borrowings	31K	-	-	-	-
Current Portion of Long-Term Debt	83.31M	210K	210K	210K	108M
Current Portion of Leases	1.98M	1.68M	1.69M	2.28M	2.59M
Current Income Taxes Payable	22K	28K	279K	364K	348K
Unearned Revenue Current, Total	210K	114K	50K	197K	187K
Other Current Liabilities	50K	50K	850K	7.84M	758K
Total Current Liabilities	100M	17.34M	15.04M	32.1M	141M
Long-Term Debt	-	58.05M	54.65M	87.79M	16.33M
Long-Term Leases	13.86M	12.27M	10.87M	10.48M	10.84M
Deferred Tax Liability Non Current	4.86M	5.06M	2.3M	4.56M	4.67M
Other Non Current Liabilities	-	1.57M	526K	3.55M	4.1M
Total Liabilities	119M	94.28M	83.38M	138M	177M
Common Stock, Total	1.21M	1.96M	1.97M	4.19M	40K
Additional Paid In Capital	16.19M	46.46M	46.62M	63.4M	63.8M
Retained Earnings	12.56M	-26.7M	-48.64M	-79.12M	-116M
Treasury Stock	-24.92M	-24.92M	-24.92M	-24.92M	-24.92M
Comprehensive Income and Other	-5.36M	1.02M	1.03M	1.27M	5.27M
Total Common Equity	-319K	-2.18M	-23.95M	-35.18M	-71.98M
Total Equity	-319K	-2.18M	-23.95M	-35.18M	-71.98M
Total Liabilities And Equity	119M	92.1M	59.44M	103M	105M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	5.38M	7.64M	9.47M	18.63M	20.25M
ECS Total Common Shares Outstanding	4.18M	7.62M	7.67M	17.96M	18.71M
Book Value / Share	-0.08	-0.29	-3.12	-1.96	-3.85
Tangible Book Value	-18.62M	-20.44M	-25.12M	-65.57M	-105M
Tangible Book Value Per Share	-4.45	-2.68	-3.28	-3.65	-5.63
Total Debt	99.19M	72.2M	67.43M	101M	138M
Net Debt	73.28M	65.62M	63.74M	95.6M	133M
Debt Equivalent Oper. Leases	-	-	-	-	-
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	13.65M	12.09M	10.05M	10.03M	11.48M
Inventories - Work In Process, Total	5.55M	3.95M	4.5M	4.99M	3.74M
Inventories - Finished Goods, Total	9.93M	6.46M	5.38M	4.35M	3.6M
Land - (BS)	24.33M	24.68M	24.27M	26.78M	28.56M
Machinery, Total	36.54M	38.22M	39.04M	41.03M	41.44M
Full Time Employees	477	398	380	401	287
Accumulated Allowance for Doubtful Accounts (Supple)	2.99M	2.69M	2.32M	2.29M	-

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	875K	-41.01M	-24.02M	-31.79M	-37.38M
Depreciation & Amortization - CF	1.83M	1.41M	830K	675K	1.3M
Amortization of Goodwill and Intangible Assets - (CF)	435K	444K	945K	-	4K
Depreciation & Amortization, Total	2.26M	1.85M	1.78M	675K	1.3M
Amortization of Deferred Charges, Total - (CF)	1.06M	961K	-	1.19M	1.38M
(Gain) Loss From Sale Of Asset	-1K	2K	-12.72M	-	-
(Gain) Loss on Sale of Investments - (CF)	-	-	1.5M	-	-
Asset Writedown & Restructuring Costs	6.36M	5.36M	9.6M	2.21M	2.18M
Stock-Based Compensation (CF)	1.1M	1.76M	2.07M	1.32M	324K
Net Cash From Discontinued Operations	-	-	2K	-	-
Other Operating Activities, Total	7.34M	31.82M	12.92M	18.13M	19.86M
Change In Accounts Receivable	6.24M	-966K	1.05M	-2.37M	4.92M
Change In Inventories	-4.41M	-877K	-971K	-1.74M	90K
Change In Accounts Payable	-7.59M	181K	-2.77M	8.18M	1.39M
Cash from Operations	13.24M	-921K	-11.56M	-4.19M	-5.93M
Capital Expenditure	-1.81M	-1.1M	-803K	-405K	-88K
Divestitures	-	-	28.16M	-	-
Sale (Purchase) of Intangible assets	-6.88M	-4.88M	-1.9M	-9.66M	-6.14M
Investment in Marketable and Equity Securities, Total	-	-	-700K	-	-
Other Investing Activities, Total	-	-	-	-12.9M	-
Cash from Investing	-8.69M	-5.98M	24.76M	-22.97M	-6.22M
Short Term Debt Issued, Total	1.76M	-	-	-	-
Long-Term Debt Issued, Total	-	100M	5M	30.18M	15M
Total Debt Issued	1.76M	100M	5M	30.18M	15M
Long-Term Debt Repaid, Total	-2.94M	-124M	-12.37M	-2.5M	-3.19M
Total Debt Repaid	-2.94M	-124M	-12.37M	-2.5M	-3.19M
Issuance of Common Stock	-	25.4M	-	7.39M	547K
Repurchase of Common Stock	-	-	-	-	-
Other Financing Activities, Total	-4.84M	-13.72M	-8.67M	-6.25M	-308K
Cash from Financing	-6.02M	-12.32M	-16.04M	28.81M	12.05M
Foreign Exchange Rate Adjustments	55K	-112K	-44K	-175K	71K
Net Change in Cash	-1.42M	-19.33M	-2.89M	1.48M	-29K
Supplemental Items
Cash Interest Paid	4.01M	7.92M	7.62M	6.25M	308K
Cash Income Tax Paid (Refund)	-1.62M	15K	-312K	-1.01M	346K
Levered Free Cash Flow	-774K	-8.47M	-12.83M	-7.03M	-11.2M
Unlevered Free Cash Flow	3.66M	-1.26M	-6.49M	414K	-3.19M
Change In Net Working Capital	-2.36M	-6.97M	-2.42M	-15.86M	-5.99M
Net Debt Issued / Repaid	-1.18M	-24M	-7.37M	27.67M	11.81M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	4.46	-6.47	-13.26	-10.53	-5.72
Return on Total Capital	5.54	-8.08	-17.71	-15.71	-9.07
Return On Equity %	-73.21	3.29K	282.24	105.58	69.76
Return on Common Equity	-73.21	3.29K	282.24	105.58	69.76
Margin Analysis
Gross Profit Margin %	40.96	29.48	34.22	34.83	38.57
SG&A Margin	26.55	39	54.81	46.81	56.35
EBITDA Margin %	11.35	-12.73	-25.17	-21.17	-18.83
EBITA Margin %	10.04	-14.01	-26.63	-22.26	-21.79
EBIT Margin %	9.57	-14.6	-28.29	-22.26	-21.8
Income From Continuing Operations Margin %	1	-54.83	-64.87	-50.71	-85.36
Net Income Margin %	0.94	-54.84	-42.26	-51.64	-85.36
Net Avail. For Common Margin %	1	-54.83	-64.87	-50.71	-85.36
Normalized Net Income Margin	2.04	-18.58	-27.55	-27.19	-32.19
Levered Free Cash Flow Margin	-0.83	-11.33	-22.58	-11.42	-25.57
Unlevered Free Cash Flow Margin	3.94	-1.68	-11.42	0.67	-7.29
Asset Turnover
Asset Turnover	0.75	0.71	0.75	0.76	0.42
Fixed Assets Turnover	12.85	12.89	15.01	18.9	8.82
Receivables Turnover (Average Receivables)	5.22	5.42	4.59	4.88	3.72
Inventory Turnover (Average Inventory)	1.85	2.04	1.76	2.04	1.41
Short Term Liquidity
Current Ratio	0.72	2.69	2.6	1.28	0.25
Quick Ratio	0.41	1.28	1.11	0.62	0.11
Operating Cash Flow to Current Liabilities	0.13	-0.05	-0.77	-0.13	-0.04
Days Sales Outstanding (Average Receivables)	69.86	67.4	79.6	74.97	98.22
Days Outstanding Inventory (Average Inventory)	197.31	178.68	207.17	179.32	259.2
Average Days Payable Outstanding	47.04	51.33	52.9	49.59	126.81
Cash Conversion Cycle (Average Days)	220.13	194.75	233.87	204.7	230.6
Long Term Solvency
Total Debt/Equity	-31.09K	-3.32K	-281.54	-286.42	-191.69
Total Debt / Total Capital	100.32	103.11	155.08	153.64	209.06
LT Debt/Equity	-4.35K	-3.23K	-273.59	-279.32	-37.75
Long-Term Debt / Total Capital	14.02	100.41	150.7	149.84	41.17
Total Liabilities / Total Assets	100.27	102.36	140.29	134.06	168.45
EBIT / Interest Expense	1.25	-0.95	-1.58	-1.15	-0.75
EBITDA / Interest Expense	1.57	-0.79	-1.41	-1.09	-0.64
(EBITDA - Capex) / Interest Expense	1.32	-0.88	-1.49	-1.13	-0.65
Total Debt / EBITDA	8.89	-7.96	-4.71	-7.73	-16.74
Net Debt / EBITDA	6.56	-7.24	-4.46	-7.34	-16.12
Total Debt / (EBITDA - Capex)	10.61	-7.1	-4.46	-7.5	-16.56
Net Debt / (EBITDA - Capex)	7.84	-6.45	-4.22	-7.12	-15.95
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-8.84	-19.56	-9.1	8.31	-28.87
Gross Profit, 1 Yr. Growth %	-21.62	-42.1	12.64	10.24	-21.24
EBITDA, 1 Yr. Growth %	-46.77	-190.26	27.52	-8.02	-36.73
EBITA, 1 Yr. Growth %	-50.58	-212.21	19.9	-8.61	-30.37
EBIT, 1 Yr. Growth %	-51.75	-222.68	19.01	-14.03	-30.34
Earnings From Cont. Operations, 1 Yr. Growth %	-115.45	-4.51K	-15.41	-15.33	19.73
Net Income, 1 Yr. Growth %	-113.7	-4.79K	-41.43	32.35	17.58
Normalized Net Income, 1 Yr. Growth %	-74.2	-834.52	0.98	7.49	-15.79
Diluted EPS Before Extra, 1 Yr. Growth %	-113.9	-3.14K	-25.45	-62.63	0.6
Accounts Receivable, 1 Yr. Growth %	-33.83	-5.12	-15.64	22.34	-30.18
Inventory, 1 Yr. Growth %	-3.63	-22.73	-11.42	-2.8	-2.82
Net Property, Plant and Equip., 1 Yr. Growth %	-30.76	-3.99	-66.7	144.24	14.74
Total Assets, 1 Yr. Growth %	-8.82	-22.53	-35.47	73.79	1.82
Tangible Book Value, 1 Yr. Growth %	-17.73	9.75	22.89	161.08	60.74
Common Equity, 1 Yr. Growth %	-85.62	582.13	1K	46.9	104.6
Cash From Operations, 1 Yr. Growth %	-44.27	-106.96	1.15K	-63.74	41.47
Capital Expenditures, 1 Yr. Growth %	-43.52	-39.24	-27.07	-49.56	-78.27
Levered Free Cash Flow, 1 Yr. Growth %	-112.33	995.38	26.37	-44.87	59.31
Unlevered Free Cash Flow, 1 Yr. Growth %	-62.38	-134.38	120.19	-106.46	-871.07
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	1.39	-14.37	-16.31	-0.78	-12.23
Gross Profit, 2 Yr. CAGR %	-0.06	-32.63	-23.75	11.43	-6.82
EBITDA, 2 Yr. CAGR %	44.15	-33.49	24.84	7.78	-23.72
EBITA, 2 Yr. CAGR %	91.3	-27.35	43.42	4.2	-20.23
EBIT, 2 Yr. CAGR %	597.42	-23.06	57.79	0.72	-22.61
Earnings From Cont. Operations, 2 Yr. CAGR %	-82.1	161.13	346.42	-15.37	0.69
Net Income, 2 Yr. CAGR %	-82.6	153.37	423.92	-11.96	24.75
Normalized Net Income, 2 Yr. CAGR %	-27.14	37.67	548.37	3.89	-4.86
Diluted EPS Before Extra, 2 Yr. CAGR %	-83.1	105.55	229.89	-47.21	-35.36
Accounts Receivable, 2 Yr. CAGR %	-16.56	-20.77	-10.54	1.59	-7.58
Inventory, 2 Yr. CAGR %	-4.63	-13.71	-17.27	-7.21	-2.81
Net Property, Plant and Equip., 2 Yr. CAGR %	-20.19	-18.47	-43.46	-9.82	67.4
Total Assets, 2 Yr. CAGR %	-4.76	-15.96	-29.3	5.9	33.02
Tangible Book Value, 2 Yr. CAGR %	7.33	-4.98	16.14	79.12	104.86
Common Equity, 2 Yr. CAGR %	-73.98	-0.97	766.46	302.09	73.37
Cash From Operations, 2 Yr. CAGR %	56.33	-80.31	-6.56	113.32	-28.37
Capital Expenditures, 2 Yr. CAGR %	-7.87	-41.42	-33.43	-39.35	-66.9
Levered Free Cash Flow, 2 Yr. CAGR %	-68	16.21	136.89	-16.81	-6.28
Unlevered Free Cash Flow, 2 Yr. CAGR %	3.2	-64.04	74.11	-62.52	-29.4
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-1.42	-6.14	-17.71	-8.8	-11.2
Gross Profit, 3 Yr. CAGR %	-2.79	-16.68	-26.3	-13.78	-0.74
EBITDA, 3 Yr. CAGR %	-0.86	23.32	-12.73	12.39	-9.76
EBITA, 3 Yr. CAGR %	-0.68	60.14	-8.65	23.04	-8.9
EBIT, 3 Yr. CAGR %	9.9	290.77	-4.48	28.5	-10.93
Earnings From Cont. Operations, 3 Yr. CAGR %	-65.52	12.25	83.03	156.49	-4.99
Net Income, 3 Yr. CAGR %	-65.91	12.35	55.5	231.2	-3.04
Normalized Net Income, 3 Yr. CAGR %	-6.88	57.4	28.78	255.53	-3.13
Diluted EPS Before Extra, 3 Yr. CAGR %	-66.71	-4.6	49.6	59.63	-32.21
Accounts Receivable, 3 Yr. CAGR %	-15.6	-12.91	-19.09	-0.7	-10.35
Inventory, 3 Yr. CAGR %	-1.38	-11.09	-12.95	-12.7	-5.77
Net Property, Plant and Equip., 3 Yr. CAGR %	3.34	-15.12	-39.51	-7.92	-2.28
Total Assets, 3 Yr. CAGR %	-7.79	-11.1	-23.04	-4.58	4.52
Tangible Book Value, 3 Yr. CAGR %	2.35	8.13	3.53	52.14	72.77
Common Equity, 3 Yr. CAGR %	-80.65	-22.71	120.99	379.56	221.01
Cash From Operations, 3 Yr. CAGR %	22.34	-44.6	-21.35	-31.84	86.03
Capital Expenditures, 3 Yr. CAGR %	-37.79	-19.81	-36.98	-39.31	-56.92
Levered Free Cash Flow, 3 Yr. CAGR %	-62.26	3.91	26.94	45.39	3.31
Unlevered Free Cash Flow, 3 Yr. CAGR %	-31.13	-28.46	-12.63	-42.18	2.69
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-1.37	-5.48	-10.15	-7.41	-15.56
Gross Profit, 5 Yr. CAGR %	-2.62	-12.05	-14.04	-10.87	-19.05
EBITDA, 5 Yr. CAGR %	-6.1	-2.27	5.73	20.74	-17.47
EBITA, 5 Yr. CAGR %	-3.73	3.59	9.69	39.97	-13.63
EBIT, 5 Yr. CAGR %	1.37	14.79	19.12	137.07	-12.34
Earnings From Cont. Operations, 5 Yr. CAGR %	-52.54	1.18	10.23	1.49	44.11
Net Income, 5 Yr. CAGR %	-61.29	0.36	1.69	1.91	42.38
Normalized Net Income, 5 Yr. CAGR %	-12.86	46.71	46.22	36.26	13.97
Diluted EPS Before Extra, 5 Yr. CAGR %	-52.65	-7.55	-2.33	-23.79	6.94
Accounts Receivable, 5 Yr. CAGR %	-5.58	-7.5	-13.61	-7.37	-14.67
Inventory, 5 Yr. CAGR %	-2.22	-7.26	-8.07	-9.56	-9.03
Net Property, Plant and Equip., 5 Yr. CAGR %	-15.08	-0.41	-18.81	-13.04	-9.11
Total Assets, 5 Yr. CAGR %	-13.78	-13.75	-17.08	-4.65	-4.21
Tangible Book Value, 5 Yr. CAGR %	-22.92	-10.31	7.66	32.32	36.02
Common Equity, 5 Yr. CAGR %	-68.85	-49.34	-11.48	49.49	100.55
Cash From Operations, 5 Yr. CAGR %	5.29	-36.96	9.84	-5	-24.24
Capital Expenditures, 5 Yr. CAGR %	-15.54	-25.63	-36.08	-28.28	-51.29
Levered Free Cash Flow, 5 Yr. CAGR %	-15.3	-5.25	-2.26	-1.43	12.28
Unlevered Free Cash Flow, 5 Yr. CAGR %	17.65	-30.41	-10.35	-34.52	-19.99